Skip to search formSkip to main contentSkip to account menu

YM 529

Known as: ONO-5920, YM-529, YM529 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

DiphosphonatesImidazolesMinodronic Acid
YH 529

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines
Review
2006
Review
2006
Reviewer ' s report Anti-tumor effect of bisphosphonate ( YM 529 ) on non-small cell lung cancer
General In the present study, authors investigated the effects of YM529 in preventing the growth of non-small cell lung cancer… 
Review
2006
Review
2006
Author ' s response to reviews Anti-tumor effect of bisphosphonate ( YM 529 ) on non-small cell lung cancer
In the present study, authors investigated the effects of YM529 in preventing the growth of non-small cell lung cancer (NSCLC… 
2005
2005
Effect ofYM 529 on aModel ofMandibular Invasion by Oral Squamous Cell Carcinoma inMice
Purpose:This study examined themechanisms of osteoclast-mediated bone invasion in amodel of oral squamous cell carcinoma (OSCC… 
2004
2004
Effects of YM529, a novel minodronic acid, on adjuvant arthritis in rats
2004
2004
Effects of YM 529 , a novel minodronic acid , on adjuvant arthritis in rats
Objective The effects of a new third-generation bisphosphonate, YM529, on both the development and treatment of adjuvant… 
2004
2004
Minodronate (YM-529) がラット坐骨神経切除で誘発した廃用性骨萎縮におよぼす影響
2003
2003
Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis
2002
2002
成熟期II型コラーゲン関節炎ラットに Minodronate (ONO-5920) 投与が及ぼす効果 : 骨量, 骨微細構造, 骨動態の関係
2001
2001
A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells